The use of a mutant TNF-α as a vaccine adjuvant for the induction of mucosal immune responses
Authors:
- Yasuhiro AbeYAYasuhiro Abe
- Yasuo YoshiokaYYYasuo Yoshioka
- Kazufumi KatayamaKKKazufumi Katayama
- Tetsuya NomuraTNTetsuya Nomura
- Tokuyuki YoshidaTYTokuyuki Yoshida
- Kohei YamashitaKYKohei Yamashita
- Tomoaki YoshikawaTYTomoaki Yoshikawa
- Yuichi KawaiYKYuichi Kawai
- Tadanori MayumiTMTadanori Mayumi
- Takachika HiroiTHTakachika Hiroi
- Norio ItohNINorio Itoh
- 1 October 2009
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 30 (29) , 5869-5876
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Health Sciences Foundation
- Takeda Science Foundation
- Ministry of Health, Labour and Welfare
This publication has 37 references indexed in Scilit:
- Critical issues in mucosal immunity for HIV-1 vaccine developmentJournal of Allergy and Clinical Immunology, 2008
- Tumour necrosis factor‐α‐mediated human polymeric immunoglobulin receptor expression is regulated by both mitogen‐activated protein kinase and phosphatidylinositol‐3‐kinase in HT‐29 cell lineImmunology, 2008
- Transcutaneous β-amyloid immunization reduces cerebral β-amyloid deposits without T cell infiltration and microhemorrhageProceedings of the National Academy of Sciences, 2007
- Tumor Necrosis Factor-α Is a Potent Endogenous Mutagen that Promotes Cellular TransformationCancer Research, 2006
- Optimal site-specific PEGylation of mutant TNF-α improves its antitumor potencyBiochemical and Biophysical Research Communications, 2004
- Tumor necrosis factor signalingCell Death & Differentiation, 2003
- Vaccines and VaccinationNew England Journal of Medicine, 2001
- Epithelial Barrier Defects in HT‐29/B6 Colonic Cell Monolayers Induced by Tumor Necrosis Factor‐αAnnals of the New York Academy of Sciences, 2000
- TNF Registered in Europe: Does TNF Get a Second Chance?Journal of Immunotherapy, 2000
- Clinical applications of TNF-α in cancerCurrent Opinion in Immunology, 1998